J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India
· Delayed Price · Currency is INR 2,069.90
+18.70 (0.91%)
At close: Mar 9, 2026
BOM:506943 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 332,340 | 252,540 | 255,986 | 152,503 | 121,735 | 96,881 | Upgrade
|
| Market Cap Growth | 28.17% | -1.35% | 67.86% | 25.27% | 25.65% | 146.60% | Upgrade
|
| Enterprise Value | 326,808 | 249,373 | 256,557 | 154,282 | 114,656 | 92,331 | Upgrade
|
| Last Close Price | 2069.90 | 1605.23 | 1618.48 | 960.35 | 760.85 | 599.51 | Upgrade
|
| PE Ratio | 43.61 | 38.29 | 46.32 | 37.21 | 31.59 | 21.63 | Upgrade
|
| Forward PE | 35.90 | 31.77 | 35.43 | 29.01 | 24.70 | 23.07 | Upgrade
|
| PS Ratio | 7.93 | 6.45 | 7.35 | 4.84 | 5.02 | 4.74 | Upgrade
|
| PB Ratio | 8.73 | 7.36 | 8.76 | 6.15 | 5.69 | 5.34 | Upgrade
|
| P/TBV Ratio | 13.43 | 12.27 | 17.33 | 13.86 | 8.66 | 5.63 | Upgrade
|
| P/FCF Ratio | - | 31.38 | 37.99 | 27.42 | 113.49 | 36.28 | Upgrade
|
| P/OCF Ratio | - | 27.98 | 31.97 | 24.26 | 71.55 | 30.78 | Upgrade
|
| PEG Ratio | 1.85 | 1.53 | 1.43 | 1.49 | 1.40 | 0.99 | Upgrade
|
| EV/Sales Ratio | 7.79 | 6.37 | 7.36 | 4.90 | 4.73 | 4.52 | Upgrade
|
| EV/EBITDA Ratio | 28.49 | 24.48 | 29.11 | 21.92 | 21.29 | 16.79 | Upgrade
|
| EV/EBIT Ratio | 34.29 | 29.00 | 34.01 | 26.07 | 24.19 | 18.86 | Upgrade
|
| EV/FCF Ratio | - | 30.98 | 38.08 | 27.74 | 106.89 | 34.58 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.13 | 0.23 | 0.03 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.04 | 0.03 | 0.42 | 0.81 | 0.10 | 0.08 | Upgrade
|
| Debt / FCF Ratio | - | 0.04 | 0.56 | 1.03 | 0.51 | 0.17 | Upgrade
|
| Net Debt / Equity Ratio | -0.14 | -0.12 | -0.03 | 0.12 | 0.00 | -0.36 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.49 | -0.41 | -0.09 | 0.43 | 0.00 | -1.18 | Upgrade
|
| Net Debt / FCF Ratio | - | -0.52 | -0.12 | 0.55 | -0.02 | -2.43 | Upgrade
|
| Asset Turnover | - | 0.95 | 0.92 | 1.02 | 1.00 | 1.01 | Upgrade
|
| Inventory Turnover | - | 2.63 | 2.60 | 2.85 | 2.29 | 2.32 | Upgrade
|
| Quick Ratio | - | 2.02 | 1.34 | 1.57 | 1.70 | 3.22 | Upgrade
|
| Current Ratio | - | 3.04 | 2.13 | 2.76 | 3.27 | 4.50 | Upgrade
|
| Return on Equity (ROE) | - | 20.75% | 20.45% | 17.75% | 19.54% | 27.59% | Upgrade
|
| Return on Assets (ROA) | - | 13.00% | 12.49% | 12.01% | 12.22% | 15.08% | Upgrade
|
| Return on Invested Capital (ROIC) | 21.85% | 21.84% | 19.73% | 17.76% | 21.95% | 32.33% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 23.60% | 24.10% | 19.70% | 21.30% | 25.90% | Upgrade
|
| Earnings Yield | 2.27% | 2.61% | 2.16% | 2.69% | 3.17% | 4.62% | Upgrade
|
| FCF Yield | - | 3.19% | 2.63% | 3.65% | 0.88% | 2.76% | Upgrade
|
| Dividend Yield | 0.95% | 0.97% | 0.76% | 0.92% | 1.08% | 1.38% | Upgrade
|
| Payout Ratio | - | 35.94% | 28.41% | 31.13% | 33.10% | 16.35% | Upgrade
|
| Buyback Yield / Dilution | 0.27% | -0.07% | -1.26% | -1.23% | -0.10% | 2.86% | Upgrade
|
| Total Shareholder Return | 1.23% | 0.90% | -0.50% | -0.31% | 0.99% | 4.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.